WED, MARCH 15, 2023 15:45 CET
BPC Instruments CEO, Dr. Jing Liu, comments on the financial result of 2022, the company’s strategy for keeping its leading position in its niche markets, and what shareholders can expect from BPC over the coming year.
CEO Dr. Jing Liu is interviewed by the Swedish financial news agency Börsvärlden about BPC’s first year as a listed company and the company’s strategy going forward.
“…We have achieved an impressive net sales growth of 27 %, which is a testament to our team’s hard work and commitment to innovation, quality, and customer satisfaction. As we move forward into 2023, I am pleased to say that we are off to a great start. We have already achieved many long-term strategic milestones, and I am confident that we will continue our momentum throughout the rest of the year,” comments CEO Dr. Jing Liu when asked about the company’s past year’s achievements and what shareholders can expect from 2023.
The interview, in Swedish, is available via the following link: https://borsvarlden.com/artiklar/Bpc-instruments-stabilt-bolag
For information regarding BPC Instruments, please contact:
BPC Instruments AB
Dr. Jing Liu, CEO
Tel: +46 (0) 46 16 39 51
About BPC Instruments AB
BPC Instruments is a global Swedish-based pioneering technology company developing and offering analytical instruments enabling more efficient, reliable, and higher quality of research and analysis for industries in renewable bioenergy and environmental biotechnology. The result is not only higher accuracy and precision, but also significant reduction in time consumption and labour requirement for performing analysis. BPC Instruments’ innovative products offer high-quality hardware and software based on deep knowledge and experience of target applications. The solutions are the first of their kind, making the company a pioneer in its field. Today, BPC Instruments exports to 60+ countries around the world. BPC is listed on Spotlight Stock Market in Sweden. For more information, please visit BPC’s webpage: www.bpcinstruments.com